The aims of the present study were: 1) to confirm the presence of DCS in adults with MMD; and 2) to explore the relationship of DCS with cerebral perfusion as measured by dynamic susceptibility contrast perfusion MR imaging. Since the arterial occlusive lesions in MMD essentially affect the ICAs, we hypothesized that DCS was correlated with an impairment of frontal perfusion.
Methods

Patient Population
We identified adults patients with MMD followed at our institution and invited them to participate in this prospective study. Moyamoya disease was diagnosed according to the criteria established by the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. 12 Diagnosis was based on digital substraction angiography or MR angiography. Exclusion criteria were: age less than 18 years, the presence of any associated disease potentially responsible for the arterial lesions, 21, 38 any associated neurological disorder other than MMD that could influence neuropsychological assessment, and severe disability defined as a score greater than 3 on the modified Rankin Scale.
Patients were included between March 2008 and December 2008, before any surgery procedure and, for patients with a history of stroke, at least 3 months after stroke onset. All included patients underwent a standardized neuropsychological assessment test battery and cerebral perfusion MR imaging in which acetazolamide was administered. The study was reviewed and approved by the medical institutional review board and local ethics committee. All patients gave written informed consent.
Neuropsychological Assessment
We used a standardized and validated neuropsychological assessment test battery focusing on executive function. Tests of executive function included letter (R) and category (animals) fluency tests, the TMTB, the Stroop interference condition, the Brixton test, and the modified version of the WCST (number of categories [WSCT-C] and number of perseverations [WSCT-P]). Attention and speed of mental processing were measured with the TMTA, and the colored dots and word sections of the Stroop test. The expressive language was assessed with the verbal fluency tests and with the Naming and Recognition Test of 80 common objects. Perceptive organization was evaluated with the Rey figure copy and the Hooper test. Memory was assessed with the immediate and delayed 16 free and cued recalls and Rey figure recall.
All patients underwent testing in the same order and during a single session of approximately 2.5 hours. The same certified neuropsychologist (F.M.) administered the tests to all patients without knowledge of findings on perfusion MR imaging.
The individual raw scores were converted into z scores adjusted for age, sex, and education level according to published normative data. The results were expressed in standard deviation except immediate and delayed recall, which were expressed using raw scores obtained on the first recall. For all tests, mild impairment was defined as a z score between 1.7 (5th percentile) and 2.49 SDs below the normative mean, and severe impairment was defined as a z score ≥ 2.5 SDs below the normative mean. 4, 9, 14, 44 For immediate and delayed recall, mild impairment was defined as a raw score between the 10th and the 5th percentile, and severe impairment was defined as a raw score less than 5th percentile. 45 Because of the high number of tests, we considered executive dysfunction when 3 or more tests of executive function or attention were impaired. This defined DCS.
14,15
Perfusion-Weighted Magnetic Resonance Imaging
Imaging Processing. Dynamic susceptibility contrastenhanced MR imaging studies were performed with a 1.5-T MR imaging unit (Gyroscan NT Intera; Philips, Best, the Netherlands), by using a single-shot gradient echo type of echo planar sequence with a standard head coil. The imaging parameters were as follows: TE 30 msec; flip angle 40°; acquisition matrix 128 × 128; FOV 69; and slice thickness 7 mm. Gadopentetate dimeglumine at 0.05 mmol/kg body weight was administered as a bolus through the antecubital vein with an automated injection at a rate of 6 ml/second, followed by a 20-ml saline flush. Perfusion weighted imaging was performed before and 15-20 minutes after injection of 15 mg/kg of acetazolamide. In the meantime, the other sequences were obtained: diffusion weighted images, T2-weighted and FLAIR images, and MR TOF angiography of the cerebral arteries. The patients received a 10-ml prebolus of contrast agent to reduce the permanent effect of Gd on the second perfusion sequence because of incomplete clearance. 17 The imaging data were stored and analyzed using a commercially available image analysis software (Viewforum Station, Philips). All analyses were performed by the same neuroradiologist (I.C.) blinded to neuropsychological findings.
Regions of Interest. Hemodynamic parameters were evaluated in each patient by manually placing a series of 22 ROIs over the cerebral cortex (frontal and temporoparietal) supplied by the ICA circulation and the cerebellum on both sides. Each ROI consisted of a 1-cm-diameter circle along the cortical rim. We carefully avoided large vessels and infarcted areas.
Hemodynamic Parameters Analysis. Data were analyzed without deconvolution by using summary parameters obtained directly from the concentration-time curve. The use of an arterial input function is not recommended in MMD owing to the proximal stenoses and the presence of collaterals that can introduce delay and dispersion in the bolus of contrast. 5, 6 These potential errors can be minimized by using quantitative regional analysis based on summary parameters and reference ROIs in the cerebellum. 5, 7, 43, 48 Perfusion weighted image analysis produced parametric maps of equivalent values of MTT and CBV in each cerebral and cerebellar ROI. For each patient, we averaged rMTT and rCBV values over the sides and over frontal, temporoparietal, and cerebellar ROIs to generate one measure from the frontal cortex, one measure from the temporoparietal cortex, and one measure from the cerebellum. We calculated relative values of rCBV (rCBV ratio) and rMTT (rMTT delay) using the cerebellum as a control region. Relative values of rCBV corresponded to the ratios of frontal or temporoparietal rCBV to the cerebellar rCBV; rMTT delay was defined as the frontal or temporoparietal rMTT minus cerebellar rMTT.
We calculated the relative rCVR using the frontal or temporoparietal rCBV ratio before and after acetazolamide administration. 2, 35, 39 The calculation was based on the equation: rCVR = ([rCBV ratio after acetazolamide − rCBV ratio before acetazolamide]/rCBV ratio before acetazolamide) × 100. We considered that rCVR was qualitatively reduced when rCVR was less than or equal to 0 (meaning that the increase in rCBV in the cerebellum was equal to or greater than in cerebral ROIs), and preserved when rCVR was greater than 0.
We did not use the CBF ratio because previous studies with perfusion MR imaging in MMD showed that absolute CBF or CBF ratio values were not reliable and did not correlate well with CBF values on PET scanning. 6, 7, 43 In contrast, the CBV ratio and MTT delay correlated with CBV, oxygen extraction fraction, and misery perfusion state as measured with PET scanning. 43 
Statistical Analysis
Data were analyzed using nonparametric tests. Hemodynamic parameters (rCVR, rCBV ratio, and rMTT delay) were compared among patients with DCS and patients without DCS using the Mann-Whitney U-test. The correlation of impaired frontal or temporal rCVR with DCS was evaluated using the Fisher exact test. All reported p values are 2 sided. The significance level was set at p < 0.05. Statistical analysis was performed with SPPS 14.0 software.
Results
Patient Population
Eleven patients with MMD were identified. One patient refused to undergo neuropsychological assessment. Thus, 10 patients, 8 women and 2 men, were included. Mean age was 40.4 years (range 29-73 years). Ethnicities were Caucasian (8 patients) and African-West-Indian (2 patients).
Seven patients had a history of ischemic stroke. Moyamoya disease was diagnosed because of severe headache in the 3 remaining patients, including 1 with a cortical subarachnoid hemorrhage. The mean duration of disease from diagnosis to inclusion in the present study was 36.6 ± 27 months.
All patients were right handed. Five patients were in full-time paid employment, and 1 was in partial-time paid employment. Three patients were unemployed, and 1 was retired.
The cerebral MR imaging revealed no recent infarct on diffusion weighted images. Eight patients had at least 1 old cerebral infarct on T2-weighted images. Bilateral multiple infarcts were seen in 5 patients. In 1 patient imaging reveled the sequelae of a small subarachnoid hemorrhage located over the left frontal cortex on T2*-weighted images without cerebral infarction. Parenchymal MR imaging demonstrated normal findings in 1 patient. The MMD was bilateral in 9 patients and unilateral in 1 at inclusion.
Neuropsychological Assessment
The mean z scores for each test are presented in Table 1 (raw scores for immediate and delay recall). Mean z scores for the TMTA, TMTB, WSCT-C, and Stroop interference condition were in the impaired range. Numbers of patients with score impairment to each of these tests were 3 of 10, 7 of 10, 6 of 10, and 4 of 10, respectively. Impairment was mild for the TMTA and Stroop interference condition, and severe for the TMTB and WCST-C. Mean z scores for the remaining tests were within normal limits.
Six patients had a defined DCS. The z scores on TMTB and WCST-C were impaired in all patients with DCS. Among the 4 patients without DCS, 2 had all z scores in the normal range. Clinical and radiological findings according to the presence/absence of DCS are presented in Table 2 . Bilateral infarctions were more common in patients with DCS.
Correlation Between DCS and Cerebral Hemodynamic Measurements
Frontal rCVR was significantly lower in patients with DCS than in those without DCS (mean ± SD: −13.5 ± 13.2% vs 20.3 ± 21.3%; p = 0.019, Mann-Whitney U-test).
All but 1 patient with DCS had a reduced frontal rCVR according to our definition, whereas frontal rCVR was positive in all patients without DCS (p = 0.048, Fisher exact test). Frontal rMTT delay, frontal rCBV ratio, temporoparietal rCVR, temporoparietal rMTT delay, and temporoparietal rCBV ratio were not different among patients with and patients without DCS (Table 3) .
Discussion
This is the first study to investigate the relationship between cognitive dysfunction and cerebral hemodynamic impairment, as measured by perfusion MR imaging, in adult patients with MMD. We found a high incidence of DCS in these individuals, and DCS was correlated with reduced rCVR in frontal areas.
Based on previous results in MMD, neuropsychological assessment in our study particularly explored executive functioning, with numerous subtests of each executive function. Our results suggest a high rate of cognitive impairment essentially affecting executive function. Six of 10 patients had DCS according to our definition. The lowest mean z scores were obtained for the TMTA, TMTB, WSCT-C, and Stroop interference condition, and the highest rates of impairment were for the TMTB, WSCT-C, and Stroop interference condition, indicating that speed of data processing, mental flexibility, set-shifting, rules deduction, and response inhibition were the most affected abilities in these patients. Other cognitive functions were not significantly affected. Tests of language and visuomotor abilities were within normal limits. Verbal memory, as measured with free recall, was impaired in 5 patients. However, scores improved after cued recall. Such a memory impairment status with improvement of recall with cuing is commonly observed in DCS with involvement of frontal lobes. 16 Previous published research on cognitive dysfunction in adults with MMD has been limited to a few case reports and 1 case series of 36 US adults. Our findings are generally consistent with these studies. Executive dysfunction was found in the 3 previous case studies in which it was evaluated. 3, 25, 32 Karzmark and colleagues 26 reported cognitive impairment in 11 (31%) of 36 patients affecting mostly executive functioning. The cut-off values for test impairment and the definition of cognitive impairment that they used were different from those in the present study. However, applying their methods (z scores below 1 SD of normative means, and impaired scores on 50% of tests) to our material did not alter the findings: the same 6 patients with DCS were still classified as cognitively impaired. Of interest, approximately half of the patients reported by Karzmark and colleagues exhibited an impairment of TMTB, in good agreement with our findings. 26 Thus, the TMTB might be a useful screening test for DCS in MMD.
Frontal rCVR was significantly lower in patients with DCS than those without DCS. Other parameters of frontal perfusion and temporoparietal rCVR were not correlated with DCS. When cerebral perfusion pressure falls, CBF is initially maintained by vasodilation of resistance arterioles, a phenomenon known as autoregulation. Autoregulatory vasodilation is identified as an increase in CBV. With further reduction in cerebral pressure perfusion, autoregulation is exhausted and CBF falls as a function of pressure. 36, 40 Measurement of CBV may not be a reliable parameter of reduced perfusion pressure in some patients with cerebrovascular disease. It may be normal or even reduced due to reduced metabolic demand in patients with ischemic neuronal injury. Also, a reduction in CBV may follow the vascular collapse that occurs with severe reductions in perfusion pressure. 11 The acetazolamide challenge, which induces a small acidosis and cerebral vasodilatation, can theoretically be used to overcome these problems and identify patients with exhausted capacity of cerebral vasodilation whatever the basal value of CBV. 13, 35, 37, 46 In our study, the significant association of DCS with impaired frontal rCVR and the lack of association of DCS with frontal rCBV are consistent with this interpretation and suggest that CVR calculated with CBV may be a more accurate marker of reduced tissue perfusion than baseline CBV alone in adult patients with MMD.
Our study is, to our knowledge, the first attempt to correlate MR imaging measurement of brain perfusion with acetazolamide and cognitive function in adult patients with MMD. Findings regarding cerebral perfusion are in good agreement with previous studies measuring CVR with acetazolamide and SPECT. These studies demonstrated a more pronounced alteration in CVR in the frontal lobes than in other brain areas. 22, 29, 31 The impairment of frontal perfusion in MMD can be explained by the distribution of arterial occlusive lesions, usually limited to the ICAs and sparing the posterior circulation, and the development of pial collateral supply from posterior cerebral arteries to middle and anterior cerebral arteries. This results in a more efficient revascularization of posterior areas of the cerebral hemispheres.
Our findings may suggest that DCS was secondary to impaired frontal perfusion. However, the significant correlation between these 2 variables does not necessarily mean a causal relationship. Most patients in our study had a history of stroke. Magnetic resonance imaging demonstrated at least one cerebral infarction in 8 patients, and cerebral infarctions were more common in the group with DCS. There is a lot of evidence of executive dysfunction following stroke in the presence of other cerebrovascular diseases.
14 Thus, we cannot exclude that DCS and frontal perfusion impairment were secondary to ischemic brain damage and reduced metabolic demand in these patients. The question of whether DCS can occur in MMD independently from cerebral infarction could not be addressed in our study because the small sample size did not permit us to perform a multivariable analysis. Further studies including a larger number of patients are needed to address this issue.
Several previous cohort studies have shown that MMD in US, or European, non-Asian adults is a potentially severe disease owing to the high incidence of ischemic stroke during follow-up in these patients. 8, 18, 27 Our findings suggest that the severity of the disease is also related to a high rate of cognitive impairment. The only available treatment for MMD is surgical revascularization of the affected cerebral hemispheres. Experience in children indicates that intellectual function can improve after surgical revascularization. 33 Future studies should determine whether DCS and associated frontal perfusion impairment in adults can both be reversed by surgical revascularization.
Our study has several limitations. First, because of the small sample size, our findings should be considered preliminary and interpreted with caution. They need to be confirmed in a larger number of patients. However, the findings were statistically significant and consistent with previous knowledge on MMD.
Patients were included after a relatively long period of disease evolution. This may explain the high prevalence of DCS in our study. Longitudinal studies are needed to determine the prevalence of DCS at an early stage and whether the prevalence of DCS increases with disease duration.
Our neuropsychological test battery did not contain a depression scale. Depressive syndrome can be a confounding factor, responsible for poor scores on some subtests of executive function. 1, 10 Nevertheless, no patient was treated for depression, and the qualitative assessment of mood disorders by the neuropsychologist was negative in all patients.
Our results cannot be compared with MMD in children because, in contrast to studies in children, we did not assess intellectual functioning. We decided not to perform tests of intellectual capacity to reduce the duration of neuropsychological assessment and because a previous study showed that these functions were quite preserved in adults. 26 Our study did not include a control group of healthy individuals. Thus, we could not determine whether frontal rCVR in patients without DCS was normal or relatively reduced (albeit to a lesser extent than in patients with DCS).
We did not use an arterial input function for perfusion parameter measurement because the presence of collaterals in MMD may introduce delay and dispersion in the bolus of contrast, making quantification less reliable. Thus, we used quantitative regional analysis based on summary parameters and using ROIs in the cerebellum as a reference. This method showed good correlation with absolute values of hemodynamic parameters measured with PET scanning in a previous study in patients with MMD. 43 Because the vertebral and basilar arteries are not affected in MMD, the cerebellum can be used as a reference region. Negative values of rCVR estimated from rCBV ratios may result from an intracerebral steal phenomenon or a still positive but weaker response to acetazolamide administration than in the reference region. 47 This limitation, however, does not alter our main finding of a correlation between DCS and reduced frontal rCVR.
Conclusions
In our preliminary study, we found that DCS was common in adults with MMD. Dysexecutive cognitive syndrome was associated with reduced rCVR in the frontal lobes. Our findings suggest that some neuropsychological tests could be used as clinical markers of compromised cerebral perfusion in these patients. Further studies are needed to determine whether DCS can occur in the absence of brain infarction and whether surgical revascularization can improve both executive function and frontal perfusion in adult patients with MMD.
